Clinical Trial Update: MetfoRmin and Its Effects on Left Ventricular Hypertrophy in Normotensive Patients With Coronary Artery Disease [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating MetfoRmin and its effects on left ventricular hypertrophy in normotensive patients with coronary artery disease; status completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Insulin Resistance
• Left Ventricular Hypertrophy
• Pre-diabetes

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: University of Dundee | Conditions: Left Ventricular Hypertrophy, Insulin Resistance | Phase 4 | Status: COMPLETED